Literature DB >> 26866497

Botulinum Toxin for the Treatment of Tremor and Tics.

Mitesh Lotia1, Joseph Jankovic1.   

Abstract

The therapeutic applications of botulinum toxin (BoNT) have grown manifold since its initial approval in 1989 by the U.S. Food and Drug Administration for the treatment of strabismus, blepharospasm, and other facial spasms. Although it is the most potent biologic toxin known to man, long-term studies have established its safety in the treatment of a variety of neurologic and nonneurologic disorders. Despite a paucity of randomized controlled trials, BoNT has been found to be beneficial in treating a variety of tremors and tics when used by clinicians skilled in the administration of the drug for these hyperkinetic movement disorders. Botulinum toxin injections can provide meaningful improvement in patients with localized tremors and tics; in some cases, they may be an alternative to other treatments with more undesirable adverse effects. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26866497     DOI: 10.1055/s-0035-1571217

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  7 in total

Review 1.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  VMAT2 Inhibitors in Neuropsychiatric Disorders.

Authors:  Arjun Tarakad; Joohi Jimenez-Shahed
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

Review 3.  Botulinum Toxin Treatment of Movement Disorders.

Authors:  Yasaman Safarpour; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2018-02-24       Impact factor: 3.598

Review 4.  History of Botulinum Toxin Treatment in Movement Disorders.

Authors:  Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-11-28

5.  Hereditary geniospasm in a mother and son treated with botulinum toxin injection: A case report.

Authors:  Clare Perkins; Wei Jia; James Rainsbury; Andrew Lux
Journal:  SAGE Open Med Case Rep       Date:  2021-03-24

Review 6.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

Authors:  Veit Roessner; Heike Eichele; Jeremy S Stern; Liselotte Skov; Renata Rizzo; Nanette Mol Debes; Péter Nagy; Andrea E Cavanna; Cristiano Termine; Christos Ganos; Alexander Münchau; Natalia Szejko; Danielle Cath; Kirsten R Müller-Vahl; Cara Verdellen; Andreas Hartmann; Aribert Rothenberger; Pieter J Hoekstra; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-11-10       Impact factor: 4.785

7.  Real-World Longitudinal Experience of Botulinum Toxin Therapy for Parkinson and Essential Tremor.

Authors:  Olivia Samotus; Yekta Mahdi; Mandar Jog
Journal:  Toxins (Basel)       Date:  2022-08-17       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.